Increasing Number of Patients with the Syndrome to Affect the Asperger Syndrome Market Positively
Added: (Mon Feb 25 2019)
Pressbox (Press Release) -
Transparency Market Research in its new report titled, “Asperger Syndrome Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026,” provides key insights on the asperger syndrome market. The new report anticipates that the increase in number of patients with the syndrome, unmet medical needs, improving regulatory guidelines, surge in government support, and rise in financing and repayment drive will boost the asperger syndrome market during the forecast period i.e, 2018-2026.
The report has segmented the global Asperger syndrome market in terms of diagnosis, treatment, and end-user. In terms of diagnosis, the global market is classified into DSM-IV, differential diagnosis, Gilliam Asperger’s Disorder Scale (GADS), childhood Asperger syndrome test, Krug Asperger's Disorder Index (KADI), and others.
The differential diagnosis segment can be categorized into schizophrenia spectrum, nonverbal learning disorder, Tourette syndrome, major depressive disorder, stereotypic movement disorder, personality disorder, social anxiety disorder, obsessive-compulsive disorder, pragmatic semantic disorder, bipolar disorder, and others.
In terms of treatment type, the report has split the global Asperger syndrome market into parent education & training, social skills training, speech-language therapy, applied behavioral analysis (ABA), sensory integration/occupational therapy, and medication. The medicines segment dominated the market in 2017.
The segment is further classified into various drug classes such as antipsychotics, selective serotonin reuptake inhibitors, psychiatric agents, and others. Antipsychotics include risperidone, paliperidone, and aripiprazole. Selective serotonin reuptake inhibitors include fluvoxamine, fluoxetine, sertraline, paroxetine, citalopram, and escitalopram. Psychiatric agents include atomoxetine and guanfacine.
Based on end-user, the global Asperger syndrome market is divided into clinics, hospitals, drug stores, pharmacies, diagnostic centers, and others. Hospitals is expected to be a highly lucrative segment owing to preference for treatment in these settings. Geographically, the global Asperger syndrome market is segmented into Asia Pacific, North America, Western Europe, Eastern Europe, Latin America, and Middle East & Africa. Among these, North America is expected to dominate the market owing to increase in awareness about autism spectrum disorder (ASD).
Prominent players operating in the global Asperger syndrome market are included in this report to give a better competitive analysis and these are Eli Lilly and Company, Jazz Pharmaceuticals, Allergan, Inc., Pfizer, Otsuka Pharmaceutical Company, Ltd., Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson Services, Inc., and AstraZeneca.
Request a free brochure report here - http://bit.ly/2H1gLrI
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com